|
|
|
Volumn 14, Issue 4, 2000, Pages 225-226
|
|
Calanolide looks promising.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
CALANOLIDE A;
COUMARIN DERIVATIVE;
PYRANOCOUMARIN DERIVATIVE;
ARTICLE;
DOSE RESPONSE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MALAYSIA;
PHASE 2 CLINICAL TRIAL;
PROGNOSIS;
SENSITIVITY AND SPECIFICITY;
SINGAPORE;
UNITED STATES;
ANTI-HIV AGENTS;
CLINICAL TRIALS, PHASE II;
COUMARINS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HIV INFECTIONS;
HUMANS;
MALAYSIA;
PROGNOSIS;
PYRANOCOUMARINS;
SENSITIVITY AND SPECIFICITY;
SINGAPORE;
UNITED STATES;
|
|
EID: 0034170240
PISSN: 10872914
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|